U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07135609) titled 'Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.' on Aug. 14.
Brief Summary: The current study evaluated the clinical effect and outcome of locally applied bee venom versus low-level laser therapy (LLLT) for the treatment of recurrent aphthous ulceration.
Study Start Date: April 30, 2024
Study Type: INTERVENTIONAL
Condition:
Apitoxin
Bee Venom Therapy
Management
Aphthous Ulceration
Intervention:
DEVICE: Low-level laser therapy (LLLT)
Patients managed by Low-level laser therapy (LLLT).
DRUG: Apitoxin
Patients managed with 0.3% Apitoxin Gel.
Recruitment Status: COMPLETED
Sponsor: Tanta University
Informati...